Cargando…

First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up

Detalles Bibliográficos
Autores principales: Jia, Ziqi, Wang, Yanyu, Cao, Lei, Wang, Yadong, Song, Yang, Yang, Xiaoying, Bing, Zhongxing, Cao, Zhili, Liu, Peng, Zhang, Shuyang, Chen, Zexin, Huang, Min, Yu, Yan, Han-Zhang, Han, Song, Jinlei, Christoph, Daniel C., Passaro, Antonio, Gridelli, Cesare, Hishida, Tomoyuki, Liang, Naixin, Li, Shanqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399434/
https://www.ncbi.nlm.nih.gov/pubmed/32802455
http://dx.doi.org/10.21037/jtd-20-1882
_version_ 1783566148239884288
author Jia, Ziqi
Wang, Yanyu
Cao, Lei
Wang, Yadong
Song, Yang
Yang, Xiaoying
Bing, Zhongxing
Cao, Zhili
Liu, Peng
Zhang, Shuyang
Chen, Zexin
Huang, Min
Yu, Yan
Han-Zhang, Han
Song, Jinlei
Christoph, Daniel C.
Passaro, Antonio
Gridelli, Cesare
Hishida, Tomoyuki
Liang, Naixin
Li, Shanqing
author_facet Jia, Ziqi
Wang, Yanyu
Cao, Lei
Wang, Yadong
Song, Yang
Yang, Xiaoying
Bing, Zhongxing
Cao, Zhili
Liu, Peng
Zhang, Shuyang
Chen, Zexin
Huang, Min
Yu, Yan
Han-Zhang, Han
Song, Jinlei
Christoph, Daniel C.
Passaro, Antonio
Gridelli, Cesare
Hishida, Tomoyuki
Liang, Naixin
Li, Shanqing
author_sort Jia, Ziqi
collection PubMed
description
format Online
Article
Text
id pubmed-7399434
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-73994342020-08-13 First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up Jia, Ziqi Wang, Yanyu Cao, Lei Wang, Yadong Song, Yang Yang, Xiaoying Bing, Zhongxing Cao, Zhili Liu, Peng Zhang, Shuyang Chen, Zexin Huang, Min Yu, Yan Han-Zhang, Han Song, Jinlei Christoph, Daniel C. Passaro, Antonio Gridelli, Cesare Hishida, Tomoyuki Liang, Naixin Li, Shanqing J Thorac Dis iMDT Corner AME Publishing Company 2020-07 /pmc/articles/PMC7399434/ /pubmed/32802455 http://dx.doi.org/10.21037/jtd-20-1882 Text en 2020 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle iMDT Corner
Jia, Ziqi
Wang, Yanyu
Cao, Lei
Wang, Yadong
Song, Yang
Yang, Xiaoying
Bing, Zhongxing
Cao, Zhili
Liu, Peng
Zhang, Shuyang
Chen, Zexin
Huang, Min
Yu, Yan
Han-Zhang, Han
Song, Jinlei
Christoph, Daniel C.
Passaro, Antonio
Gridelli, Cesare
Hishida, Tomoyuki
Liang, Naixin
Li, Shanqing
First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up
title First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up
title_full First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up
title_fullStr First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up
title_full_unstemmed First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up
title_short First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up
title_sort first-line treatment selection with organoids of an egfrm + tp53m stage ia1 patient with early metastatic recurrence after radical surgery and follow-up
topic iMDT Corner
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399434/
https://www.ncbi.nlm.nih.gov/pubmed/32802455
http://dx.doi.org/10.21037/jtd-20-1882
work_keys_str_mv AT jiaziqi firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup
AT wangyanyu firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup
AT caolei firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup
AT wangyadong firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup
AT songyang firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup
AT yangxiaoying firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup
AT bingzhongxing firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup
AT caozhili firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup
AT liupeng firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup
AT zhangshuyang firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup
AT chenzexin firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup
AT huangmin firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup
AT yuyan firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup
AT hanzhanghan firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup
AT songjinlei firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup
AT christophdanielc firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup
AT passaroantonio firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup
AT gridellicesare firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup
AT hishidatomoyuki firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup
AT liangnaixin firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup
AT lishanqing firstlinetreatmentselectionwithorganoidsofanegfrmtp53mstageia1patientwithearlymetastaticrecurrenceafterradicalsurgeryandfollowup